Researchers target protein that can slow down muscular dystrophy

A team of researchers at the University of Houston College of Pharmacy is reporting that by manipulating TAK1, a signaling protein that plays an important role in development of the immune system, they can slow down disease ...


Epkinly granted accelerated FDA approval for lymphoma treatment

The U.S. Food and Drug Administration has granted accelerated approval for Genmab's Epkinly (epcoritamab-bysp) for relapsed or refractory diffuse large B-cell lymphoma (DLBCL), including DLBCL arising from indolent lymphoma, ...

Diseases, Conditions, Syndromes

New study explains how a common virus can cause multiple sclerosis

Researchers at Karolinska Institutet in Sweden have found further evidence for how the Epstein-Barr virus can trigger multiple sclerosis or drive disease progression. A new study published in Science Advances shows that some ...

page 1 from 40